Skip to main content

Advertisement

Log in

Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries’ osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

  • Consensus Statement
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Summary

A consensus platform is provided by the experts of the Gulf Cooperation Council (GCC) countries’ respective osteoporosis societies, on which specific guidelines can be developed further for regional use on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis.

Introduction

Guidance is provided in a Gulf Cooperation Council (GCC) country setting on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis, which is an adaptation of the European guidance by Kanis et al., jointly published by the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). The respective osteoporosis societies of the Gulf Cooperation Council (GCC) countries assembled for a unifying consensus on the diagnosis and management of osteoporosis in postmenopausal women for the region.

Methods

The Chair for Biomarkers of Chronic Diseases (CBCD) in King Saud University (KSU), Riyadh, Kingdom of Saudi Arabia (KSA), in cooperation with the Saudi Osteoporosis Society (SOS), hosted regional experts and respective leaders from different GCC osteoporosis societies, together with an adviser from the ESCEO. An assembly of experts representing the different osteoporosis societies from Saudi Arabia, the UAE, Bahrain, Oman, and Kuwait gathered on February 15–16, 2019 in Riyadh, KSA for the formulation of a general osteoporosis consensus for the region.

Results

The following areas were covered: diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; and hip fractures, vitamin D, recommendation on which FRAX tool to follow, and the importance of country-specific FRAX® and fracture liaison services for secondary fracture prevention.

Conclusions

A platform is provided on which specific guidelines can be developed for regional use in GCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Glaser DL, Kaplan FS (1997) Osteoporosis. Definition and clinical presentation. Spine (Phila Pa 1976) 22(24 Suppl):12S–16S

    Article  CAS  Google Scholar 

  2. World Health Organization. Recommendations for preventing osteoporosis. https://www.who.int/nutrition/topics/5_population_nutrient/en/index25.html. Accessed 16 July 2019

  3. Cooper C, Campion G, Melton LJ 3rd. (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(6):285–289

    Article  CAS  PubMed  Google Scholar 

  4. Oden A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int 26(9):2243–2248

    Article  CAS  PubMed  Google Scholar 

  5. Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44

    Article  CAS  PubMed  Google Scholar 

  6. Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622

    Article  PubMed  Google Scholar 

  7. Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis–2016. Endocr Pract 22(9):1111–1118

    Article  PubMed  Google Scholar 

  8. Jassim NA, Adib G, Younis AA, Gorial FI, Maghraoui A, Suhaili AR, Murtaji A, Otom A, Masri B, Saba E, Badran F, Maalouf G, Saleh J, El Muntaser K, Zakraoui L, Al Izzi M, Ali NA, Sulaimani R, Majeed SA, Al ES (2017) Pan Arab Osteoporosis Society guidelines for osteoporosis management. Mediterr J Rheumatol 28(1):37–42

    Google Scholar 

  9. Maalouf G, Gannage-Yared MH, Ezzedine J, Larijani B, Badawi S, Rached A, Zakroui L, Masri B, Azar E, Saba E, Nammari R, Adib G, Abou Samra H, Alrawi Z, Zalman S, El Muntasser K, Tarseen R, El Kharousi W, Al-Lamki M, Alothman AN, Almarzook N, El Dessouki M, Sulaimani R, Saleh J, Suhaili AR, Khan A, Delmas P, Seeman E (2007) Middle East and North Africa consensus on osteoporosis. J Musculoskeletal Neuronal Interact 7(2):131–143

    CAS  Google Scholar 

  10. Al-Saleh Y, Sulimani R, Sabico S, Raef H, Fouda M, Alshahrani F, Al Shaker M, Al Wahabi B, Sadat-Ali M, Al Rayes H, Al Aidarous S, Saleh S, Al Ayoubi F, Al-Daghri NM (2015) 2015 guidelines for osteoporosis in Saudi Arabia: recommendations from the Saudi Osteoporosis Society. Ann Saudi Med 35(1):1–12

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kuwait Osteoporosis Guidelines (2018) http://www.kops-kw.org/uploads/frax_guidelines_2018.pdf. Accessed 16 July 2019

  12. Beshyah SA, Al-Saleh Y, EL-hajj Fuleihan G (2019) Management of osteoporosis in the Middle East and North Africa: a survey of physicians’ perceptions and practices. Arch Osteoporos 14(1):60

    Article  PubMed  Google Scholar 

  13. Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Weber DR, Zemel BS, Shepherd JA (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA-cross calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine and pediatrics. J Clin Densitom. in-press. https://doi.org/10.1016/j.jocd.2019.07.001

  14. Alkhamis A, Hassan A, Cosgrove P (2014) Financing healthcare in Gulf Cooperation Council countries: a focus on Saudi Arabia. Int J Health Plan Manage 29(1):e64–e82

    Article  Google Scholar 

  15. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos int 7(5):407–413

    Article  CAS  PubMed  Google Scholar 

  16. El-Desouki MI (1999) Osteoporosis in postmenopausal Saudi women using dual X-ray bone densitometry. Saudi Med J 20(4):283–286

    CAS  PubMed  Google Scholar 

  17. El-Desouki MI (2003) Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry. Saudi Med J 24(9):953–956

    PubMed  Google Scholar 

  18. Sadat Ali M, AlElq A (2006) Osteoporosis among male Saudi Arabs: a pilot study. Ann Saudi Med 26(6):450–454

    Article  PubMed  PubMed Central  Google Scholar 

  19. El-Desouki MI, Sulimani RA (2007) High prevalence of osteoporosis in Saudi men. Saudi Med J 28(5):774–777

    PubMed  Google Scholar 

  20. Ardawi MS, Maimany AA, Bahksh TM, Nasrat HA, Milaat WA, Al-Raddadi RM (2005) Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int 16(1):43–55

    Article  PubMed  Google Scholar 

  21. Sadat Ali M, Al-Habdan IM, Al-Turki HA, Azam MQ (2012) An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population. Ann Saudi Med 32(6):637–641

    Article  PubMed  PubMed Central  Google Scholar 

  22. Al Saleh J, Sayed ME, Monsef N, Darwish E (2016) The prevalence and the determinants of musculoskeletal diseases in Emiratis attending primary health care clinics in Dubai. Oman Med J 31(2):117–123

    Article  PubMed  PubMed Central  Google Scholar 

  23. Alsawy S (2009) Edentulism as a predictor of osteoporosis among postmenopausal Bahraini women. J Clin Densitom 12(3):389

    Article  Google Scholar 

  24. Mahussain S, Badr H, Al-Zaabi K, Mohammad M, Alnafisi N (2006) Bone mineral density in healthy Kuwaiti women. Arch Osteoporos 1(1-2):51–57

    Article  PubMed Central  Google Scholar 

  25. Al-Shoumer KA, Nair V (2012) Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait. Arch Osteoporos 7:147–153

    Article  PubMed  Google Scholar 

  26. Gupta R, Al-saeed O, Azizieh F, Albusairi A, Gupta P, Mohammed A (2012) Evaluation of bone mineral density in postmenopausal women in Kuwait. J Clin Densitom 15(2):211–216

    Article  PubMed  Google Scholar 

  27. Shukla JJ, Khandekar RB (2008) Magnitude and determinants of osteoporosis in adult population of South Sharqiya region of Oman. Saudi Med J 29(7):984–988

    PubMed  Google Scholar 

  28. Bener A, Hammoudeh M, Zirie M (2007) Prevalence and predictors of osteoporosis and the impact of life style factors on bone mineral density. APLAR Journal of Rheumatology 10:227–233

    Article  Google Scholar 

  29. The Middle East and Africa Regional Audit: Epidemiology, costs and burden of osteoporosis in 2011 (Executive Summary). https://www.iofbonehealth.org/sites/default/files/PDFs/Audit%20Middle%20East_Africa/ME_audit-executive_summary.pdf. Accessed 17 July 2019

  30. Rouzi AA, Al-Sibiani SA, Al-Senani NS, Raddadi RM, Ardawi MS (2012) Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR study. Bone 50(3):713–722

    Article  PubMed  Google Scholar 

  31. Sadat Ali M, Alfaraidy M, AlHawas A, Al-Othman AA, Al-Dakheel DA, Tayar BK (2017) Morbidity and mortality after fragility hip fracture in a Saudi Arabian population: report from a single center. J Int Med Res 45(3):1175–1180

    Article  PubMed  PubMed Central  Google Scholar 

  32. Azizieh FY (2017) Fractures in Kuwait: incidence and distribution. Risk Manag Healthc Policy 10:117–125

    Article  PubMed  PubMed Central  Google Scholar 

  33. Johansson H, Azizieh F, Al Ali N, Alessa T, Harvey NC, McCloskey E, Kanis JA (2017) FRAX- vs. T-score intervention thresholds for osteoporosis. Osteoporos Int 28(11):3099–3105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Amin TT, Al Owaifeer A, Al-Hashim H, Alwosaifer A, Alabdulqader M, Al Hulaibi F, Al Hamam A (2013) Osteoporosis among older Saudis: risk fractures and unmet needs. Arch Osteoporos 8:118

    Article  PubMed  Google Scholar 

  35. Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, Advisory Board of the National Osteoporosis Guideline Group (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25

    Article  PubMed  PubMed Central  Google Scholar 

  36. Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GE (2017) The FRAX-based Lebanese osteoporosis guidelines: rationale for a hybrid model. Osteoporos Int 28(1):12737

    Google Scholar 

  37. Kanis JA, Harvey NC, McCloskey E, Bruyere O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Jawad K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster JY (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31(1):1–12

    Article  CAS  PubMed  Google Scholar 

  38. Singh P, Kumar M, Al KS (2019) Vitamin D deficiency in the Gulf Cooperation Council: exploring the triad of genetic predisposition, the gut microbiome and the immune system. Front Immunol 10:1042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Al-Daghri NM, Al-Saleh Y, Aljohani N, Sulimani R, Al-Othman AM, Alfawaz H, Fouda M, Al-Amri F, Shahrani A, Alharbi M, ALshahrani F, Tamimi W, Sabico S, Rizzoli R, Reginster JY (2017) Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Muskuloskeletal Diseases (ESCEO). Arch Osteoporos 12(1):1

    Article  PubMed  Google Scholar 

  40. Haq A, Wimalawansa SJ, Pludowski P, Anouti FA (2018) Clinical practice guidelines for vitamin D in the United Arab Emirates. J Steroid Biochem Mol Biol 175:4–11

    Article  CAS  PubMed  Google Scholar 

  41. AlQuaiz AM, Mujammami M, Kazi Am Hasanato RM, Alodhayani A, Shaik SA, Al-Daghri NM (2019) Vitamin D cutoff point in relation to parathyroid hormone: a population based study in Riyadh city, Saudi Arabia. Arch Osteoporos 14(1):22

    Article  PubMed  Google Scholar 

  42. Sulimani RA, Mohammed AG, Alfadda AA, Alshehri SN, Al-Othman AM, Al-Daghri NM, Hanley DA, Khan AA (2016) Vitamin D deficiency and biochemical variations among urban Saudi adolescent girls according to season. Saudi Med J 37(9):1002–1008

    Article  PubMed  PubMed Central  Google Scholar 

  43. Alshahrani FM, Almalki MH, Aljohani N, Alzahrani A, Alsaleh Y, Holick MF (2013) Vitamin D: light side and best time of sunshine in Riyadh, Saudi Arabia. Dermato-Endocrinology 5(1):177–180

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to the guidance and permission provided by IOF and ESCEO in adapting the European guidelines for GCC use. The authors are grateful to the Chair for Biomarkers of Chronic Diseases, Deanship of Scientific Research Chairs in King Saud University, Riyadh, Saudi Arabia, for their support.

Author information

Authors and Affiliations

Authors

Contributions

The views expressed in this article represent the outcomes of a working group jointly organized by the Chair for Biomarkers of Chronic Diseases (NMA) and Saudi Osteoporosis Society (YS, RS) in King Saud University, Riyadh, Saudi Arabia, on February 15–16, 2019. The working group are representatives of their respective osteoporosis societies within the GCC, together with the president of ESCEO (JYR) who served as adviser, and were invited for their expertise in osteoporosis. Members of the working group (YS, NMA, TA, AA, MA, JM, SAQ, JYR, AS, and RS) were assigned topics of importance relevant to the region in advance of the meeting for discussion. Following the meeting, a first draft was made (SS) and was circulated to all including those who were not able to attend (FA, SAE) for their review and input. Following 3 rounds of review from all members, the final draft was formatted and submitted by YS. All authors met the ICMJE criteria for authorship and gave final approval of the version to be published.

Corresponding author

Correspondence to Nasser M. Al-Daghri.

Ethics declarations

Conflicts of interest

YS received speaker honoraria from Eli Lilly and Amgen. TA received speaker honoraria from Amgen and Novartis. JYR received consulting fees and/or paid advisory boards for IBSA-Genevrier, MYLAN, Radius Health, and Pierre Fabre; lecture fees when speaking at the invitation of IBSA-Genevrier, MYLAN, CNIEL, and Diary Research Council (DRC); and grant support from IBSA-Genevrier, MYLAN, CNIEL, and Radius Health. NMA, SS, TA, AA, MA, JM, SAQ, AS, and RS have no conflicts to declare.

Additional information

Endorsements

This consensus report is endorsed by the following societies:

Saudi Osteoporosis Society

Kuwait Osteoporosis Society

American Association of Clinical Endocrinologists, Gulf Chapter

Emirates Osteoporosis Society

Emirates Diabetes Society

Oman Medical Association

Bahrain Osteoporosis Society

Qatar Osteoporosis Society

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Saleh, Y., Al-Daghri, N.M., Sabico, S. et al. Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries’ osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Arch Osteoporos 15, 109 (2020). https://doi.org/10.1007/s11657-020-00778-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-020-00778-5

Keywords

Navigation